bioAffinity Technologies, Inc. (BIAFW)

US — Healthcare Sector
Peers: BIAF  XGN  APDN  RNVA  AAPJ  DPUI  CDSG 

Automate Your Wheel Strategy on BIAFW

With Tiblio's Option Bot, you can configure your own wheel strategy including BIAFW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol BIAFW
  • Rev/Share 0.5419
  • Book/Share 0.0885
  • PB 3.4437
  • Debt/Equity 0.9248
  • CurrentRatio 0.5457
  • ROIC -3.4754

 

  • MktCap 8677314.0
  • FreeCF/Share -0.409
  • PFCF -1.305
  • PE -0.509
  • Debt/Assets 0.24
  • DivYield 0
  • ROE -3.6764

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 3
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About bioAffinity Technologies, Inc. (BIAFW)

  • IPO Date
  • Website http://www.bioaffinitytech.com
  • Industry Medical - Diagnostics & Research
  • CEO Maria Zannes
  • Employees 57
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.